1. Yang D, Hendifar A, Lenz C, Togawa K, Lenz F, Lurje G, Pohl A, Winder T, Ning Y, Groshen S, Lenz H. Survival of metastatic gastric cancer: significance of age, sex and race/ethnicity. J Gastrointest Oncol. 2011;2(2):77–84.
2. Jimenez P, Pathak A, Phan A. The role of taxanes in the management of gastroesophageal cancer. J Gastrointest Oncol. 2011;2(4):240–9.
3. Tan K, Quek T, Wong N, Li K, Lim K. Emergency surgery for perforated gastric malignancy: an institution's experience and review of the literature. J Gastrointest Oncol. 2011;2(1):13–8.
4. Saglam S, Aykan N, Sakar B, Gulluoglu M, Balik E, Karanlik H. A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinoma. J Gastrointest Oncol. 2011;2(1):19–26.
5. Hopkins S, Yang G. FDG PET imaging in the staging and management of gastric cancer. J Gastrointest Oncol. 2011;2(1):39–44.